A new study led by researchers at Trinity College Dublin in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, estimates the value-based prices of these medicines across 174 countries. The study shows that while disease-modifying therapies (DMTs) may offer substantially greater health benefits than usual care, their real-world impact will depend on whether they are priced in ways that health systems can afford.

Having a biological age older than chronological age is associated with a greater likelihood of developing dementia, a new study has shown. By combining measures of biological ageing and genetic risk, researchers have identified individuals at a higher risk of developing dementia and those who will develop the disease at a younger age.

A new study in JAMA Network Open found that between 1999-2022, the annual number of excess US deaths—deaths that would not have occurred had the mortality rate in the US been the same as in other HICs—increased steadily through 2019 and then rose rapidly during the COVID-19 pandemic. By 2022, all-cause mortality rates in the US were 38 percent higher than in other HICs. An estimated 12.7 million US deaths could have been averted during this period if US mortality rates mirrored those of its peers. The authors refer to these excess US deaths as “missing Americans.”

A finger prick blood test combined with online brain testing - all done from home - could one day effectively identify people’s risk of developing dementia, according to a new study.